Cited by 978BRCA gene mutations in cancerGenetic factors in colorectal cancerPARP inhibition in cancer therapy

The DOI matches its Crossref record; 187 of the 187 references it cites were found in a registry or an index.

BRCA1 and BRCA2: 1994 and beyond

Narod, Steven A., Foulkes, William D.·2004·Nature Reviews Cancer

Open this paper in CoChat — free account

Abstract

The discovery of the first gene associated with hereditary breast cancer, BRCA1, was anticipated to greatly increase our understanding of both hereditary and sporadic forms of breast cancer, and to lead to therapeutic and preventive breakthroughs. Much has been learned during the past decade about the genetic epidemiology of breast cancer, the ethnic distribution and clinical consequences of BRCA1 and BRCA2 mutations, and the central role of DNA repair in breast cancer susceptibility. The ability to translate this knowledge into novel treatments, however, remains elusive.

Integrity signals

Registry

Crossref · 10.1038/nrc1431

Cites

187 of 187 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Molecular portraits of human breast tumours
Perou, C., Sørlie, T., Eisen, M., van de Rijn, M., Jeffrey, S., Rees, C. A., Pollack, J., Ross, D., Johnsen, H., Akslen, L., et al. (2000) · Nature · doi:10.1038/35021093 · Cited by 16,551
Gene expression profiling predicts clinical outcome of breast cancer
van 't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A. M., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T., et al. (2002) · Nature · doi:10.1038/415530a · Cited by 9,536
A Strong Candidate for the Breast and Ovarian Cancer Susceptibility Gene BRCA1
Miki, Y., Swensen, J. J., Shattuck-Eidens, D. M., Futreal, P. A., Harshman, K., Tavtigian, S. V., Liu, Q., Cochran, C., Bennett, L. M., Ding, W., et al. (1994) · Science · doi:10.1126/science.7545954 · Cited by 6,069
Self-citation
Repeated observation of breast tumor subtypes in independent gene expression data sets
Sørlie, T., Tibshirani, R. J., Parker, J. S., Hastie, T. J., Marron, J. S., Nobel, A. B., Deng, S., Johnsen, H., Pesich, R., Geisler, S. B., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0932692100 · Cited by 5,508
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
Antoniou, A., Pharoah, P. D. P., Narod, S., Risch, H. A., Eyfjord, J. E., Hopper, J. L., Loman, N., Olsson, H., Johannsson, O., Borg, Å., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/375033 · Cited by 3,680
Self-citation
Identification of the breast cancer susceptibility gene BRCA2
Wooster, R., Bignell, G. R., Lancaster, J., Swift, S., Seal, S., Mangion, J., Collins, N., Gregory, S. G., Gumbs, C. E., Micklem, G., et al. (1995) · Nature · doi:10.1038/378789a0 · Cited by 3,645
Self-citation
Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms.
Orita, M., Iwahana, H., Kanazawa, H., Hayashi, K., & Sekiya, T. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.8.2766 · Cited by 3,589
Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.
Greenblatt, M. S., Bennett, W. P., Hollstein, M., & Harris, C. C. (1994) · PubMed · Cited by 3,463
Linkage of Early-Onset Familial Breast Cancer to Chromosome 17q21
Hall, J., Lee, M. K., Newman, B. M., Morrow, J. E., Anderson, L. A., Huey, B., & King, M. (1990) · Science · doi:10.1126/science.2270482 · Cited by 2,544
The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews.
Struewing, J., Hartge, P., Wacholder, S., Baker, S. M., Berlin, M., McAdams, M., Timmerman, M. M., Brody, L., & Tucker, M. A. (1997) · New England Journal of Medicine · doi:10.1056/nejm199705153362001 · Cited by 2,399

Flagged first, then by citations

Show all 187 references

Sorted by citations

Items 701–800 of 978

Genetics of breast cancer: Contribution of BRCA1/2 genes alterations to hereditary predisposition
Brankovic-Magic, M. V., Dobričić, J., & Krivokuća, A. (2012) · Vojnosanitetski pregled · doi:10.2298/vsp110421014b · Cited by 3
Influence of estrogen and variations at the BRCA1 promoter region on transcription and translation
Rosa-Fernandes, L., da Costa, E. C. B., Vargas, F. R., & Moreira, M. A. M. (2013) · Molecular Biology Reports · doi:10.1007/s11033-013-2884-9 · Cited by 3
Breast Cancer Genetics
Apessos, A., & Nasioulas, G. (2021) · Springer eBooks · doi:10.1007/978-3-030-73147-2_3 · Cited by 3
Gynecological oncology
Bieber, E. J., Sanfilippo, J. S., Horowitz, I., & Shafi, M. I. (2015) · Cambridge University Press eBooks · doi:10.1017/cbo9781139628938.045 · Cited by 3
BRCA1 and PARP1 mRNA expression during progression from normal breast to ductal carcinoma in situ and invasive breast cancer: a laser microdissection study
Hybiak, J., Domagała, P., & Domagała, W. (2019) · Polish Journal of Pathology · doi:10.5114/pjp.2018.81694 · Cited by 3
Tumors of the Breast
Teixeira, M. R., Pandis, N., & Heim, S. (2010) · doi:10.1002/9781118010136.ch15 · Cited by 3
Comparison of a Selection of Rapid Automated DNA and RNA Extraction Technologies for Detection of Somatic or Constitutional Gene Abnormalities in Cancer Diagnosis
Lassailly, F., Mozziconacci, J., Noguchi, T., Bechlian, D., Adélaı̈de, J., Fina, F., Martin, P., Sobol, H., Xerri, L., Birnbaum, D., et al. (2007) · Cell Preservation Technology · doi:10.1089/cpt.2006.9989 · Cited by 3
Clinical applications of Genome Polymorphism Scans.
Weber, J. L. (2006) · Biology Direct · doi:10.1186/1745-6150-1-16 · Cited by 3
Impact of Genetic Polymorphism of Sulpha Transferase Genes (SULT1A) Genes on the Risk of Females with Breast Cancer in JordanPreprint
Bustami, M., Al-Shudifat, A.-E., Hussein, N., Yacoub, M., Atwa, E., Sabri, I., Abu‐Hamdah, R., Abu-Rayyan, W., Arafat, T., Badran, A., et al. (2018) · Preprints.org · doi:10.20944/preprints201710.0050.v2 · Cited by 3
Clinically Relevant Germline Mutations in a Cohort of Young Women with Breast Cancer: A Comprehensive Analysis of Hereditary-Cancer Genes from Whole-Exome SequencingPreprint
Gómez‐Flores‐Ramos, L., Dean, M. C., Jones, K. M., Wang, M., Villarreal-Garza, C. M., Álvarez-Gómez, R. M., Wegman-Ostrosky, T., Reynoso‐Noverón, N., Fragoso‐Ontiveros, V., Sánchez-Zamorano, L. M., et al. (2020) · Preprints.org · doi:10.20944/preprints202008.0718.v1 · Cited by 3
Tumors of the breast
Teixeira, M. R., Pandis, N., & Heim, S. (2015) · doi:10.1002/9781118795569.ch16 · Cited by 3
NRF1 or NRF2: Emerging Role of Redox Homeostasis on PERK/NRF/Autophagy Mediated Antioxidant in Tumor and Patient Dependent Chemo SensitivityPreprint
Dastghaib, S., Shafiee, S. M., Ramezani, F., Ashtari, N., Tabasi, F., Saffari‐Chaleshtori, J., Vakili, O., Siri, M., Igder, S., Zamani, M., et al. (2024) · Preprints.org · doi:10.20944/preprints202401.0079.v1 · Cited by 3
Analysis of GEN1 as a Breast Cancer Susceptibility Gene in Polish Women
Gliniewicz, K., Wokołorczyk, D., Kluźniak, W., Stempa, K., Huzarski, T., Rudnicka, H., Jakubowska, A., Szwiec, M., Jarkiewicz‐Tretyn, J., Cechowska, M., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26135991 · Cited by 2
Self-citation
Immunohisochemical study of BRCA1, BRCA2, and poly (ADP-ribose) polymerase-1 in ovarian tumors
Choi, S.-K., Cho, T. I., & Lee, T.-J. (2012) · Korean Journal of Obstetrics & Gynecology · doi:10.5468/kjog.2012.55.1.8 · Cited by 2
Should the BCRA1/2-mutations healthy carriers be valid candidates for hematopoietic stem cell donation?
Fresa, A., & Sica, S. (2021) · Hereditary Cancer in Clinical Practice · doi:10.1186/s13053-021-00179-w · Cited by 2
Prominent Prognostic Factors in Aggressive Breast Cancer: A Review
Nejati‐Koshki, K., Aval, S. F., Alivand, M. R., Akbarzadeh, A., & Arabzadeh, A. (2021) · International Journal of Cancer Management · doi:10.5812/ijcm.109015 · Cited by 2
Molecular genetic testing in ovarian cancer
Kubyshkin, A. V., Salieva, G. M., Фомочкина, И. И., & Vodolazhsky, D. I. (2023) · Pacific Medical Journal · doi:10.34215/1609-1175-2022-4-11-18 · Cited by 2
Association Between Germline BRCA1/2 Gene Variants and Clinicopathological Features of Ovarian Cancer
Luo, Y., Pan, R., Rao, H., Chen, X., & Yang, H. (2024) · International Journal of General Medicine · doi:10.2147/ijgm.s445660 · Cited by 2
Using Portuguese BRCA pathogenic variation as a model to study the impact of human admixture on human health
Andaluz, S., Zhao, B., Sinha, S., Lagniton, P. N. P., Costa, D. A., Ding, X., Brito, M., & Wang, S. M. (2024) · BMC Genomics · doi:10.1186/s12864-024-10311-4 · Cited by 2
Pathogenic variants in human DNA damage repair genes mostly arose after the latest human out-of-Africa migration
He, J., Kou, S. H., Li, J., Ding, X., & Wang, S. M. (2024) · Frontiers in Genetics · doi:10.3389/fgene.2024.1408952 · Cited by 2
BRCA2 germline mutation carrier with five malignancies: a case report
Su, E., Christinat, Y., McKee, T., Azzarello-Burri, S. M., Jochum, W., Fischer, S., & Rothermundt, C. A. (2024) · Hereditary Cancer in Clinical Practice · doi:10.1186/s13053-024-00302-7 · Cited by 2
Regional Differences in the Frequency of BRCA1 and BRCA2 Variants in Northeastern Japan: A Cohort Study
Shirota, H., Miyake, A., Kawamura, M., Suzuki, S., Saito, K., Yasuda, J., Shibata, H., Saito, M., Iwaya, T., Tada, H., et al. (2025) · Cancer Medicine · doi:10.1002/cam4.70443 · Cited by 2
Biomarker Discovery
Laterza, O., & Zhao, X. (2016) · AAPS advances in the pharmaceutical sciences series · doi:10.1007/978-3-319-40793-7_3 · Cited by 2
DNA Damage Sensing and Signaling
Wood, J. L., & Chen, J. (2007) · WORLD SCIENTIFIC eBooks · doi:10.1142/9789812706782_0001 · Cited by 2
"Sequencing-grade" screening for BRCA1 variants by oligo-arrays
Monaco, A., Menolascina, F., Zhao, Y., Tommasi, S., Sabatino, M., Fasano, R. M., Paradiso, A., Marincola, F. M., & Wang, E. (2008) · Journal of Translational Medicine · doi:10.1186/1479-5876-6-64 · Cited by 2
Assignment of BReast Cancer Associated 1 (BRCA1) to tammar wallaby (Macropus eugenii) chromosome 2q3 by in situ hybridization
Wakefield, M. J., & Alsop, A. E. (2005) · Cytogenetic and Genome Research · doi:10.1159/000087535 · Cited by 2
Review of: BRCA1 and cyclin D1: gate keepers in hormone responsive tissues?
Griekspoor, A., Margarido, T. C., Zwart, W. T., & Michalides, R. J. A. M. (2006) · Breast Cancer Online · doi:10.1017/s1470903106005098 · Cited by 2
Risk assessment for hereditary breast cancer: BRCA1 and BRCA2
Seenandan-Sookdeo, K.-A. I., & Sawatzky, J. V. (2010) · Canadian Oncology Nursing Journal · doi:10.5737/1181912x203107110 · Cited by 2
Animal Models for Breast Cancer Prevention Research
Wang, C., & Brown, P. H. (2011) · Springer eBooks · doi:10.1007/978-0-387-69805-2_24 · Cited by 2
From Expression Profiling to Routine Practice
Rakha, E. A., & Reis-Filho, J. S. (2009) · Cited by 2
[Genes associated to cancer].
Peralta-Rodríguez, R., Valdivia, A., Mendoza, M. C., de Rodríguez, J., Marrero–Rodríguez, D., Paniagua, L., Romero, P., Taniguchi, K., & Salcedo, M. (2015) · PubMed · Cited by 2
Prevalencia mutacional de los genes BRCA1 y BRCA2 en pacientes con cáncer de mama y ovario atendidos en el Área de Salud de La Ribera (Comunidad Valenciana, España)
Ortiz, M., Lafuente-Sanchis, A., Cuevas, J. M., & Zúñiga, Á. (2016) · Revista Española de Patología · doi:10.1016/j.patol.2016.05.004 · Cited by 2
Study of the Carrier State for Five BRCA1/BRCA2 Deleterious Mutations in Bulgarian Women with Breast Cancer
Kovacheva, K., Kamburova, Z., Popovska, S., Ivanov, I. N., Simeonova, M. N., & Angelova, P. N. (2013) · Journal of Biomedical and Clinical Research · doi:10.1515/jbcr-2015-0109 · Cited by 2
DNA EXTRACTION AND PCR DIAGNOSIS OF BREAST CANCER PATIENTS AMONG THE POPULATION OF TRIPURA.
Debbarma, A., Ghosh, P., Das, S., Kar, A., & Chowdhury, B. (2017) · International Journal of Advanced Research · doi:10.21474/ijar01/5747 · Cited by 2
Cribado radiológico de cáncer de mama en mujeres con alto riesgo
Guzmán, G. J. R., Franjo, E. D., Vacas, M. I. D. P. D. L., Borge, N. A., & Bejarano, D. (2020) · Revista de Senología y Patología Mamaria · doi:10.1016/j.senol.2020.07.013 · Cited by 2
Inbred Strain Characteristics Impact the NKT Cell Repertoire
Shissler, S. C., Bates, J. P., Hester, D., Jones, L. P., & Webb, T. J. (2021) · ImmunoHorizons · doi:10.4049/immunohorizons.2000066 · Cited by 2
Breast Cancer Prevention
Thompson, P. A., Preece, C., & Stopeck, A. (2019) · Springer eBooks · doi:10.1007/978-3-030-15935-1_16 · Cited by 2
Combining Breast and Ovarian Operations Increases Complications
Henn, D., Barrera, J. A., Sivaraj, D., Lin, J. Q., Rizk, N. M., Ma, I., Gurtner, G. C., Lee, G., & Nazerali, R. S. (2022) · Plastic & Reconstructive Surgery · doi:10.1097/prs.0000000000008984 · Cited by 2
Tumor Suppressor Genes
(2007) · Springer eBooks · doi:10.1007/978-1-4020-6784-6_3 · Cited by 2
Genes, Environment, and Cancer Disparities
Shields, A. E., Fullerton, S. M., & Olden, K. (2009) · Springer eBooks · doi:10.1007/978-0-387-89443-0_3 · Cited by 2
Personalizing prophylactic surgery in cancer: current practice and future perspectives from new genome-wide association studies
Zoras, O., Katsios, C. S., & Roukos, D. H. (2011) · Expert Review of Anticancer Therapy · doi:10.1586/era.11.22 · Cited by 2
Molecular Genetic Analysis of Familial Breast Cancer in South Africa
Agenbag, G. (2005) · SUNScholar (Stellenbosch University) · Cited by 2
Familiäres Mammakarzinom: Beratung, Gendiagnostik und Betreuung betroffener Familien
Schmutzler, R. K., & Meindl, A. (2006) · Springer eBooks · doi:10.1007/978-3-540-31748-7_14 · Cited by 2
Ovarian cancer
Rose, P. G., & Uyar, D. S. (2015) · Cambridge University Press eBooks · doi:10.1017/cbo9781139628938.053 · Cited by 1
Tumor suppressor genes and their interactions and neo-adjuvant therapy in paclitaxel resistance in cancer
Bhowmick, B., Mandal, K., & Polley, S. (2023) · World Journal of Biology Pharmacy and Health Sciences · doi:10.30574/wjbphs.2023.14.1.0158 · Cited by 1
General analysis of breast cancer patients tested for BRCA mutations and evaluation of acute radiotherapy toxicity
Gül, Ş. K. (2024) · Northern Clinics of Istanbul · doi:10.14744/nci.2023.93196 · Cited by 1
Quality of life after risk reducing mastectomy in a Portuguese cohort of BRCA pathogenic/likely pathogenic variant carriers
Raposo, M., Peleteiro, B., Magalhães, A., Torres, S. M., Ínsua-Pereira, I., Guimarães, R., Garrido, L., Costa, S., & Fougo, J. L. (2025) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-025-06231-9 · Cited by 1
β‐ TrCP overexpression enhances cisplatin sensitivity by depleting BRCA1
Jiménez‐Guerrero, R., Belmonte‐Fernández, A., González‐Moreno, M., Rodríguez‐Cordero, L., Pérez‐Valderrama, B., Herrero‐Ruiz, J., Romero, F., Sáez, C., & Japón, M. Á. (2025) · Molecular Oncology · doi:10.1002/1878-0261.70089 · Cited by 1
Expression of G-quadruplex coordinates BRCA1, CDH1, and RASSF1 via DNA methylation in mouse breast cancer cells.
Zhou, X., Jin, Z., Zhan, X., Yang, S., Jiang, Y., Wang, H., Zhang, Z., Dong, S., Xia, W., & Liu, L. (2025) · Epigenomics · doi:10.1080/17501911.2025.2577003 · Cited by 1
Frequency of Founder Mutations in BRCA1 and BRCA2 Genes in Hereditary Breast Cancers in Poland vs. Other Countries
Kulikowska, B., Panasiuk, B., & Posmyk, R. (2026) · Cancers · doi:10.3390/cancers18030492 · Cited by 1
The life history of recessive deleterious alleles as seen through the eyes of a honey bee ( Apis mellifera )
Shultz, R. R., Nixon, J. M., Ryals, D. K., Buschkoetter, A. C., Gilchrist, I. R., Given, K., Metz, B. N., Magaña, A. A., Moon, K., Thanepohn, B., et al. (2026) · Molecular Biology and Evolution · doi:10.1093/molbev/msag156 · Cited by 2
Potential Tumor Biomarkers for Ovarian Cancer
Serio, R. N., & Billack, B. (2012) · InTech eBooks · doi:10.5772/28397 · Cited by 3
Hereditäre Mamma- und Ovarialkarzinome
Gevensleben, H., Serce, N. B., & Büttner, R. (2010) · Der Pathologe · doi:10.1007/s00292-010-1355-5 · Cited by 1
An Investigation Of Gene Networks Influenced By Low Dose Ionizing Radiation Using Statistical And Graph Theoretical Algorithms
Naswa, S. (2012) · Cited by 1
DNA‐PKcs activates the Chk2‐Brca1 pathway during mitosis to ensure chromosomal stability (736.4)
Chen, B., & Shang, Z. (2014) · The FASEB Journal · doi:10.1096/fasebj.28.1_supplement.736.4 · Cited by 1
Multiple primary malignancies in BRCA1 mutation carriers – two clinical cases
Badora-Rybicka, A., Kaleta, B., Nowara, E., Sikora-Jopek, M., Budryk, M., & Smok-Ragankiewicz, A. (2013) · Ginekologia Polska · doi:10.17772/gp/1657 · Cited by 1
Oral contraceptives as a risk factor for developing breast cancer in breast cancer (BRCA) gene carrier female in-the 30–60 years age group: a meta analysis
Ghimire, S., Shrestha, N., & Bk, B. (2015) · International Journal of Medical Research & Health Sciences · doi:10.5958/2319-5886.2015.00022.3 · Cited by 1
Breast Cancer: Epidemiological Panorama and Opportunities for Prevention
Reynoso‐Noverón, N., & Mohar, A. (2012) · Springer eBooks · doi:10.1007/978-0-85729-991-8_2 · Cited by 1
DNA Signalling/Repair Genetic Polymorphisms and BreastCancer Risk: a Review
Costa, S., Medeiros, R., & Schimitt, F. (2005) · Cited by 1
Epidemiology, Risk Factors, and Prevention
Bayraktar, S., & Arun, B. (2015) · Springer eBooks · doi:10.1007/978-3-319-22843-3_4 · Cited by 2
Tumor Suppressor Genes
Bunz, F. (2016) · Springer eBooks · doi:10.1007/978-94-017-7484-0_3 · Cited by 1
The ATM-mediated DNA-damage response
Shiloh, Y. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139046947.035 · Cited by 1
Low RAP80 mRNA Expression Correlates with Shorter Survival in Sporadic High-Grade Serous Ovarian Carcinoma
Romeo, M., Karachaliou, N., Chaid, I., Queralt, C., de Aguirre, I., Gómez, M. D. C., Sanchez-Ronco, M., Raduà, J., Ramírez, J. L., & Rosell, R. (2016) · The International Journal of Biological Markers · doi:10.5301/jbm.5000223 · Cited by 1
Oncogenética: cánceres de mama hereditarios
Perre, P. V., Imbert‐Bouteille, M., & Pujol, P. (2019) · EMC - Ginecología-Obstetricia · doi:10.1016/s1283-081x(19)42497-1 · Cited by 1
Molecular Biology
Wilczynski, S. P. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-3966-2.00006-0 · Cited by 2
Functional evidence (II) protein and enzyme function
Monteiro, Á. N. A., Nepomuceno, T. C., de Wind, N., Fernandes, V. C., Elias, A. B. R., & Carvalho, M. A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820519-8.00014-4 · Cited by 1
Radiological Screening for Hereditary Cancer Predisposition Syndromes
Kahraman, G., Çeltikçi, P., & Karasu, Ş. (2021) · Springer eBooks · doi:10.1007/978-3-030-66853-2_42 · Cited by 1
Molecular Diagnosis of Genetic Diseases
Grody, W. W. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0974-2.00070-1 · Cited by 1
Co nás učí nádory. Paralely v chování buněk a lidí
Šmardová, J. (2021) · Masarykova univerzita eBooks · doi:10.5817/cz.muni.m210-9700-2021 · Cited by 1
Gene mutation can be treated in breast cancer by gene therapy
Mahmood, S. (2021) · International Journal of Clinical Biochemistry and Research · doi:10.18231/j.ijcbr.2021.050 · Cited by 1
Hereditary Ovarian Cancer
Masuda, K., Satake, M., & Aoki, D. (2021) · Springer eBooks · doi:10.1007/978-981-16-4521-1_7 · Cited by 1
CLINICAL CASE: SYNCHRONOUS MALIGNANCY: LEFT BREAST AND OVARIAN CANCER ASSOCIATED WITH HEREDITARY BRCA1: 5382 INS C - MUTATION
Кравченко, О. В., Bashtan, O. P., Чорнобай, А. В., Mukovoz, O. E., & Hahal, O. V. (2023) · Bulletin of Problems Biology and Medicine · doi:10.29254/2077-4214-2023-2-169-244-251 · Cited by 1
Meta-analysis of Genetic polymorphism of Enhancer of Zeste Homolog2 gene in cancer susceptibility
Gautam, N., Kaur, M., & Kashyap, S. (2023) · Journal of Cancer Research and Therapeutics · doi:10.4103/jcrt.jcrt_1112_21 · Cited by 1
From Churchill to Elephants: The Role of Protective Genes against Cancer
Gazzellone, A., & Sangiorgi, E. (2024) · Genes · doi:10.3390/genes15010118 · Cited by 1
Affinity-Based Clinical Biomarkers for Early Disease Detection
Ghosh, G., & Sharma, R. (2024) · Springer eBooks · doi:10.1007/978-981-97-5473-1_3 · Cited by 1
Heat Shock Proteins in Triple-Negative Breast Cancer (TNBC) Treatment
Kaur, P., Singh, T., Galukande, M., Krishnan, S., & Asea, A. A. A. (2015) · Heat shock proteins · doi:10.1007/978-3-319-17211-8_8 · Cited by 2
Regulatory T Cells
Thornton, A. M. (2010) · Elsevier eBooks · doi:10.1016/b978-0-08-046884-6.00605-9 · Cited by 1
Operative ÜBerlegungen beim Familiôren Mammakarzinom
Bachleitner‐Hofmann, T., & Taucher, S. (2007) · Springer eBooks · doi:10.1007/978-3-211-29685-1_6 · Cited by 1
Mouse Models of Breast Cancer: Deceptions that Reveal the Truth
Couto, J. P., & Bentires‐Alj, M. (2017) · Springer eBooks · doi:10.1007/978-3-319-48848-6_6 · Cited by 1
The Human Genome
Coleman, W. B. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-802761-5.00006-7 · Cited by 1
Identification of a novel breast cancer‑causing mutation in the BRCA1 gene by targeted next generation sequencing: A case report
Wang, Y., Jiang, D., Zhao, Q., Huang, H., Zhang, X., Cui, Y., Liu, J., Wu, J., Lin, K., Chen, W., et al. (2018) · Oncology Letters · doi:10.3892/ol.2018.9139 · Cited by 1
Multigene Cancer Panels: Implications for Pre- and Post-test Genetic Counseling
Grady, M. C., Kolla, K. A., & Peshkin, B. N. (2019) · Current Genetic Medicine Reports · doi:10.1007/s40142-019-00173-8 · Cited by 1
1H, 13C and 15N backbone resonance assignment of BRCA1 fragment 219–504
Górka, M., Żerko, S., Konrat, R., Koźmiński, W., & Kurzbach, D. (2020) · Biomolecular NMR Assignments · doi:10.1007/s12104-020-09963-6 · Cited by 1
Molecular Genetic Factors Of Breast Cancer Development (Review)
Нусратиллаевич, А. А., & Tukhtaboeva, M. T. (2020) · The American Journal of Medical Sciences and Pharmaceutical Research · doi:10.37547/tajmspr/volume02issue07-14 · Cited by 1
Managing a woman with BRCA mutations? Shared decision-making is key
Schrager (2020) · The Journal of Family Practice · doi:10.12788/jfp.0003 · Cited by 2
Paclitaxel and chemoresistance
Wu, Z., Wang, J., Cui, Q., Xu, X., & Chen, Z. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-90951-8.00002-3 · Cited by 1
What Is Bioanalytical Chemistry? Scientific Opportunities with Immediate Impact
Ferreira, V. G., Feitor, J. F., Almeida, M. B., Cardoso, D. R., & Carrilho, E. (2021) · Springer eBooks · doi:10.1007/978-3-030-82381-8_1 · Cited by 1
Tumor Suppressor Genes
Bunz, F. (2022) · Springer eBooks · doi:10.1007/978-3-030-99387-0_3 · Cited by 1
Prophylactic, Risk-Reducing Surgery in Unaffected BRCA-Positive Women: Quality Of Life, Sexual Functioning and Psychological Well-Being
Tollin, S. (2011) · Digital Commons - University of South Florida (University of South Florida) · Cited by 1
Determinação de mutações e polimorfismo nos genes BRCA1 e BRCA2 em pacientes com câncer de mama com indicação para teste genético
Escobar, K. A. (2011) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2011.tde-05092011-152557 · Cited by 1
A novel BRCA1 mutation in a Spanish patient with ovarian cancer
Salgado, J., Gil, C., Robles, M., & García‐Foncillas, J. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-008-9907-6 · Cited by 1
endomÉvaluation du risque de cancer du sein héréditaire : BRCA1 et BRCA2
Seenandan-Sookdeo, K.-A. I., & Sawatzky, J. V. (2010) · Canadian Oncology Nursing Journal · doi:10.5737/1181912x203111115 · Cited by 1
Management of a woman with a family history of breast cancer
Lynch, E., & Eeles, R. A. (2006) · Women s Health Medicine · doi:10.1383/wohm.2006.3.1.28 · Cited by 1
The founder mutation BRCA1c.2845insA identified in a fallopian tube cancer patient: a case report
Damayanti, Z., Ali, A., Iau, P. T. C., Ilancheran, A., & Sng, J. H. (2006) · International Journal of Gynecological Cancer · doi:10.1111/j.1525-1438.2006.00221.x · Cited by 1
Chemical, Pharmacokinetic and Biological Aspects of Platinum-Based Drugs
Yachnin, J. (2005) · Figshare · Cited by 1
FAMILY HISTORY AND BREAST CANCER SUSCEPTIBILITY
Margolin, S. (2006) · Cited by 1
Novel Sequence Variants and a High Frequency of Recurrent Polymorphisms inBRCA1Gene in Breast Cancer Women of North Coastal Andhra Pradesh
Vijayalakshmi, A., Lakshmi, V., Veerraju, P., & Rao, V. R. (2011) · International Journal of Human Genetics · doi:10.1080/09723757.2011.11886135 · Cited by 1
Genetic Predisposition to Male and Female Breast Cancer
Syrjäkoski, K. (2004) · Tampere University Institutional Repository (Tampere University) · Cited by 1
Clinical characteristics and outcomes of BRCA-associated ovarian cancer (OC): Genotype and survival.
Engelstaedter, V., Cristea, M. C., Garber, J. E., Neuhausen, S. L., Frankel, P. H., Sand, S. R., Steele, L., Matulonis, U. A., Liu, J. F., & Weitzel, J. N. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.15_suppl.5017 · Cited by 1
Cancer Genes, Genomes, and the Environment
Strausberg, R. L. (2009) · Elsevier eBooks · doi:10.1016/b978-0-12-369420-1.00067-6 · Cited by 1

Authors: Narod, S. A., & Foulkes, W. D.
Affiliations: Sunnybrook Health Science Centre (CA)
McGill University (CA)
Corresponding author: Narod, Steven A.
ORCID: Narod, Steven A.
Foulkes, William D.
Venue: Nature Reviews Cancer
Publisher: Springer Science and Business Media LLC
Published: 2004-09
Volume: 4
Issue: 9
Pages: 665-676
ISSN: 1474-175X (ISSN-L)
1474-1768
DOI: 10.1038/nrc1431
OpenAlex: W2091961739
Cited by: 967
References: 187
Citations by year: 2026: 13 · 2025: 29 · 2024: 30 · 2023: 37 · 2022: 36 · 2021: 40 · 2020: 30 · 2019: 31 · 2018: 33 · 2017: 35 · 2016: 38 · 2015: 53 · 2014: 38 · 2013: 43 · 2012: 59
FWCI: 6.57
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature reviews. Cancer (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › BRCA gene mutations in cancer
Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
Health Sciences › Medicine › Oncology › PARP inhibition in cancer therapy
Keywords: BRCA1, BRCA2, hereditary breast cancer, genetic susceptibility, DNA repair, genetic epidemiology, breast cancer prevention, breast cancer treatment
MeSH terms: Breast Neoplasms, DNA Damage, DNA Repair, Female, Humans, Mutation, Molecular Epidemiology, Genes, BRCA1, Genetic Predisposition to Disease, Genes, BRCA2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

BRCA1 and BRCA2: 1994 and beyond

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks